Clinical Trial Update: A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients [Phase 4]

View source ↗

Summary

Phase 4 randomized study comparing duloxetine to placebo in adults with major depressive disorder, evaluating energy and vitality; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2009-07-17